OrbiMed Capital GP V LLC insider trades: Adicet Bio (ACET) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where OrbiMed Capital GP V LLC reports to the SEC
and 10 more companies
Open-market buys and sales
61 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | ACET | ↓ Sell | 104,658 | $6.45 | $675K | Indirect | Apr 9, 2026 (1d) |
| Oct 23, 2025 | PMVP | ↓ Sell | 1,000,000 | $1.52 | $1.5M | Indirect | Oct 27, 2025 (4d) |
| Oct 8, 2025 | ACET | ↑ Buy | 5,000,000 | $1.00 | $5.0M | Indirect | Oct 10, 2025 (2d) |
| Sep 10, 2025 | PMVP | ↓ Sell | 500,000 | $1.80 | $900K | Indirect | Sep 12, 2025 (2d) |
| Jun 27, 2025 | CRVS | ↓ Sell | 1,176,332 | $4.16 | $4.9M | Indirect | Jul 1, 2025 (4d) |
| Jan 25, 2024 | ACET | ↑ Buy | 3,125,000 | $2.40 | $7.5M | Indirect | Jan 26, 2024 (1d) |
| Nov 22, 2023 | PMVP | ↓ Sell | 87,786 | $2.23 | $196K | Indirect | Nov 24, 2023 (2d) |
| Jun 27, 2023 | ACET | ↑ Buy | 875,000 | $2.09 | $1.8M | Indirect | Jun 29, 2023 (2d) |
| Nov 25, 2022 | TCDA | ↓ Sell | 10,280,947 | $0.21 | $2.2M | Indirect | Nov 25, 2022 (0d) |
| Nov 8, 2022 | CMPX | ↑ Buy | 402,000 | $3.21 | $1.3M | Indirect | Nov 10, 2022 (2d) |
| May 26, 2022 | PMVP | ↓ Sell | 26,253 | $15.93 | $418K | Indirect | May 31, 2022 (5d) |
| May 13, 2022 | CMPX | ↑ Buy | 192,516 | $2.18 | $420K | Indirect | May 13, 2022 (0d) |
| May 10, 2022 | CMPX | ↑ Buy | 125,359 | $1.57 | $197K | Indirect | May 10, 2022 (0d) |
| Mar 31, 2022 | PMVP | ↓ Sell | 474,500 | $21.63 | $10.3M | Indirect | Mar 31, 2022 (0d) |
| Nov 4, 2021 | CMPX | ↑ Buy | 5,357,143 | $3.50 | $18.8M | Indirect | Nov 8, 2021 (4d) |
| Sep 20, 2021 | CRVS | ↓ Sell | 1,109,644 | $6.09 | $6.8M | Indirect | Sep 22, 2021 (2d) |
| Feb 17, 2021 | CRVS | ↑ Buy | 1,285,714 | $3.50 | $4.5M | Indirect | Feb 19, 2021 (2d) |
| Dec 8, 2020 | ARPO | ↓ Sell | 21,400 | $1.96 | $42K | Indirect | Dec 10, 2020 (2d) |
| Sep 25, 2020 | PMVP | ↑ Buy | 475,000 | $18.00 | $8.6M | Indirect | Sep 29, 2020 (4d) |
| Aug 18, 2020 | INSP | ↓ Sell | 138,443 | $107.82 | $14.9M | Indirect | Aug 19, 2020 (1d) |
| Aug 14, 2020 | INSP | ↓ Sell | 92,187 | $108.58 | $10.0M | Indirect | Aug 14, 2020 (0d) |
| Aug 11, 2020 | INSP | ↓ Sell | 116,570 | $105.65 | $12.3M | Indirect | Aug 11, 2020 (0d) |
| Jun 19, 2020 | NONE | ↑ Buy | 1,455,132 | $5.00 | $7.3M | Direct | Jun 23, 2020 (4d) |
| Mar 6, 2020 | INSP | ↓ Sell | 500,000 | $83.52 | $41.8M | Indirect | Mar 10, 2020 (4d) |
| Mar 3, 2020 | INSP | ↓ Sell | 500,000 | $84.25 | $42.1M | Indirect | Mar 5, 2020 (2d) |
| Dec 11, 2019 | TCDA | ↓ Sell | 1,500,000 | $40.00 | $60.0M | By OrbiMed Private Investments V, LP | Dec 12, 2019 (1d) |
| Nov 27, 2019 | INSP | ↓ Sell | 124,000 | $70.69 | $8.8M | Indirect | Nov 29, 2019 (2d) |
| Aug 6, 2019 | CRVS | ↑ Buy | 142,656 | $3.51 | $501K | Indirect | Aug 8, 2019 (2d) |
| Jul 1, 2019 | CRVS | ↑ Buy | 657,344 | $3.72 | $2.4M | Indirect | Jul 1, 2019 (0d) |
| Apr 3, 2019 | TCDA | ↑ Buy | 225,000 | $36.00 | $8.1M | By OrbiMed Private Investments V, LP | Apr 5, 2019 (2d) |
| Mar 8, 2019 | INSP | ↓ Sell | 358,449 | $57.23 | $20.5M | Indirect | Mar 11, 2019 (3d) |
| Dec 11, 2018 | INSP | ↓ Sell | 614,772 | $37.60 | $23.1M | Indirect | Dec 13, 2018 (2d) |
| Oct 19, 2018 | SIBN | ↑ Buy | 200,000 | $15.00 | $3.0M | By OrbiMed Private Investments V, LP | Oct 19, 2018 (0d) |
| Jul 2, 2018 | TCDA | ↑ Buy | 368,421 | $19.00 | $7.0M | By OrbiMed Private Investments V, LP | Jul 2, 2018 (0d) |
| Jun 28, 2018 | ARPO | ↑ Buy | 777,500 | $3.85 | $3.0M | Indirect | Jul 2, 2018 (4d) |
| Jun 6, 2018 | ADAP | ↓ Sell | 18,700 | $13.56 | $254K | Indirect | Jun 6, 2018 (0d) |
| Jun 1, 2018 | ADAP | ↓ Sell | 171,000 | $13.51 | $2.3M | Indirect | Jun 1, 2018 (0d) |
| May 22, 2018 | RYTM | ↓ Sell | 19,580 | $30.43 | $596K | Indirect | May 24, 2018 (2d) |
| May 21, 2018 | RYTM | ↓ Sell | 131,636 | $30.88 | $4.1M | Indirect | May 21, 2018 (0d) |
| May 14, 2018 | ADAP | ↓ Sell | 10,300 | $13.50 | $139K | Indirect | May 16, 2018 (2d) |
| May 7, 2018 | INSP | ↑ Buy | 312,500 | $16.00 | $5.0M | Direct | May 9, 2018 (2d) |
| Mar 29, 2018 | ADAP | ↓ Sell | 1,048,067 | $11.50 | $12.1M | Indirect | Mar 29, 2018 (0d) |
| Mar 12, 2018 | CRVS | ↑ Buy | 588,235 | $8.50 | $5.0M | Indirect | Mar 14, 2018 (2d) |
| Dec 8, 2017 | LOXO | ↓ Sell | 250,000 | $82.50 | $20.6M | Indirect | Dec 12, 2017 (4d) |
| Nov 22, 2017 | LOXO | ↓ Sell | 267,000 | $75.00 | $20.0M | Indirect | Nov 27, 2017 (5d) |
| Nov 16, 2017 | LOXO | ↓ Sell | 270,000 | $74.26 | $20.1M | Indirect | Nov 20, 2017 (4d) |
| Oct 10, 2017 | RYTM | ↑ Buy | 355,000 | $17.00 | $6.0M | Indirect | Oct 10, 2017 (0d) |
| Mar 27, 2017 | ADAP | ↑ Buy | 1,190,476 | $4.20 | $5.0M | Indirect | Mar 28, 2017 (1d) |
| Mar 15, 2017 | NONE | ↑ Buy | 762,995 | $5.00 | $3.8M | Indirect | Mar 17, 2017 (2d) |
| Feb 21, 2017 | AGLE | ↑ Buy | 109,300 | $5.16 | $564K | Indirect | Feb 21, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ACET insiders
Open-market trades in the last 12 months
About OrbiMed Capital GP V LLC's insider trades
OrbiMed Capital GP V LLC is a 10% owner of Adicet Bio (ACET). Since Aug 6, 2014, it has reported 32 open-market purchases worth $134.8M and 29 sales worth $353.6M on SEC Form 4. In the last 12 months: 1 sale ($675K).
Its filings also include conversions (9 filings), grants and awards (4 filings), option exercises (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACET insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.